Skip to main navigation
Investor Relations
Who We Are
Management
Board of Directors
Our Science
Dismutase Mimetics
Reducing Oral Mucositis (OM)
Increasing Anti-Cancer Efficacy of Radiotherapy
Publications
Our Pipeline
Avasopasem (GC4419)
GC4711
Clinical Trials
Investors
IR Home
News & Events
Stock Information
Corporate Governance
SEC Filings
Shareholder Services
Contact Us
Event Details
Galera at H.C. Wainwright BioConnect Conference
Jan 10, 2022 at 7:00 AM EST
Click here for webcast
